Financhill
Buy
52

CSL Quote, Financials, Valuation and Earnings

Last price:
$370.05
Seasonality move :
2.38%
Day range:
$375.62 - $386.13
52-week range:
$311.41 - $481.26
Dividend yield:
1.05%
P/E ratio:
14.15x
P/S ratio:
3.51x
P/B ratio:
7.59x
Volume:
760K
Avg. volume:
381.6K
1-year change:
-8.87%
Market cap:
$16.4B
Revenue:
$5B
EPS (TTM):
$26.86

Earnings Data

Next earnings date for CSL
Jul 24
2025
Most recent earnings per share
$3.20
Missed by $0.22
(Apr 23/2025)
Consensus Estimate
$3.42
(Apr 23/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CSL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
07/24/2025 Q2 $1.5B -- -- $6.68 --
04/23/2025 Q1 $1.1B $1.1B $3.20 $3.42 -$0.22
02/04/2025 Q4 $1.2B $1.1B $3.57 $4.42 -$0.85
10/24/2024 Q3 $1.4B $1.3B $5.25 $5.82 -$0.57
07/24/2024 Q2 $1.5B $1.5B $14.84 $6.02 $8.82
04/25/2024 Q1 $996.2M $1.1B $3.97 $2.82 $1.15
02/06/2024 Q4 $1.1B $1.1B $4.20 $3.55 $0.65
10/26/2023 Q3 -- -- $5.29 $4.55 $0.75
07/26/2023 Q2 -- -- $3.79 $4.68 -$0.89
04/27/2023 Q1 -- -- $1.96 $2.60 -$0.64
02/07/2023 Q4 -- -- $3.33 $3.63 -$0.30
10/27/2022 Q3 -- -- $4.83 $5.43 -$0.60
07/27/2022 Q2 -- -- $5.73 $4.99 $0.74
04/28/2022 Q1 -- -- $3.66 $2.47 $1.19
02/10/2022 Q4 -- -- $2.41 $2.67 -$0.26
10/21/2021 Q3 -- -- $2.67 $2.75 -$0.08
07/22/2021 Q2 -- -- $1.87 $2.12 -$0.25
04/22/2021 Q1 -- -- $0.97 $0.69 $0.28
02/04/2021 Q4 -- -- $1.49 $1.20 $0.29
10/20/2020 Q3 -- -- $1.87 $1.72 $0.15
07/21/2020 Q2 -- -- $1.36 $1.14 $0.22
04/21/2020 Q1 -- -- $1.09 $1.02 $0.07
02/06/2020 Q4 -- -- $1.78 $1.62 $0.16
10/22/2019 Q3 -- -- $2.40 $2.29 $0.11
07/23/2019 Q2 -- -- $2.65 $2.35 $0.30
04/23/2019 Q1 -- -- $1.36 $1.13 $0.23
02/07/2019 Q4 -- -- $1.47 -- --
10/23/2018 Q3 -- -- $1.64 -- --
07/24/2018 Q2 -- -- $1.85 -- --
04/24/2018 Q1 -- -- $4.94 -- --
02/08/2018 Q4 -- -- $1.82 -- --
10/24/2017 Q3 -- -- $1.37 -- --
07/25/2017 Q2 -- -- $1.58 -- --
04/27/2017 Q1 -- -- $0.94 -- --
02/09/2017 Q4 -- -- $1.16 -- --
10/25/2016 Q3 -- -- -$0.15 -- --
07/26/2016 Q2 -- -- $1.75 -- --
04/27/2016 Q1 -- -- $1.05 -- --
02/04/2016 Q4 -- -- $1.24 -- --
10/21/2015 Q3 -- -- $1.56 -- --
07/23/2015 Q2 -- -- $1.43 -- --

Carlisle Companies Earnings Questions

  • How Much did Carlisle Companies Generate in Revenue Last Quarter?

    Carlisle Companies reported $1.1B worth of top line sales in its most recent quarter.

  • Did Carlisle Companies Beat Earnings Last Quarter?

    Carlisle Companies announced earnings per share of $3.20 which represents a miss of analyst forecast a $3.42 per share.

  • Is Carlisle Companies Profitable?

    Carlisle Companies reported $385.7M that represents $8.63 per share over the last quarter.

  • What is the Analyst Consensus for Carlisle Companies EPS Next Year?

    Carlisle Companies's earnings are forecast to decrease from $27.82 per share to $20.17 per share next year representing a decrease of -20.59%.

  • When is Carlisle Companies's Earnings Date?

    Carlisle Companies's next earnings date is July 24, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is IONQ The Next NVIDIA?
Is IONQ The Next NVIDIA?

Quantum computing startup IonQ (NYSE:IONQ) has seen its stock skyrocket…

Best AI Index Fund to Buy
Best AI Index Fund to Buy

Over the last two years, companies with a focus on…

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for Jun 2

Regeneron Pharmaceuticals [REGN] is up 0.71% over the past day.

Buy
55
RGC alert for Jun 2

Regencell Bioscience Holdings [RGC] is down 15.28% over the past day.

Sell
42
AMBA alert for Jun 2

Ambarella [AMBA] is up 0.84% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock